The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
PTP1B inhibitors as potential therapeutics in the treatment of Type 2 diabetes and obesity
Abstract
Coordinated tyrosine phosphorylation is essential for signalling pathways regulated by insulin and leptin. Type 2 diabetes and obesity are characterised by resistance to hormones insulin and leptin, possibly due to attenuated or diminished signalling from the receptors. Pharmacological agents capable of inhibiting the negative regulator(s) of the signalling pathways are expected to potentiate the action of insulin and leptin and therefore be beneficial for the treatment of Type 2 diabetes and obesity. A large body of data from cellular, biochemical, mouse and human genetic and chemical inhibitor studies have identified protein tyrosine phosphatase 1B (PTP1B) as a major negative regulator of both insulin and leptin signalling. In addition, evidence suggests that insulin and leptin action can be enhanced by the inhibition of PTP1B. Consequently, PTP1B has emerged as an attractive novel target for the treatment of both Type 2 diabetes and obesity. The link between PTP1B and diabetes and obesity has led to an avalanche of research dedicated to finding inhibitors of this phosphatase. With the combined use of structure and medicinal chemistry, several groups have demonstrated that it is feasible to obtain small-molecule PTP1B inhibitors with the requisite potency and selectivity. The challenge for the future will be to transform potent and selective small molecule PTP1B inhibitors into orally available drugs with desirable physicochemical properties and in vivo efficacies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Banting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811
Identification and expression cloning of a leptin receptor, OB-R.
Tartaglia, L. A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G. J., Campfield, L. A., Clark, F. T., Deeds, J., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90151-5 · Cited by 3,496
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Hunter, T. (2000) · Cell · doi:10.1016/s0092-8674(00)81688-8 · Cited by 2,586
Obesity and the regulation of energy balance
Spiegelman, B. M., & Flier, J. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00240-9 · Cited by 2,398
Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., Normandin, D., Cheng, A., Himms-Hagen, J., Chan, C.-C., et al. (1999) · Science · doi:10.1126/science.283.5407.1544 · Cited by 2,210
Protein kinases — the major drug targets of the twenty-first century?
Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,186
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
Mechanisms and consequences of activation of protein kinase B/Akt
Downward, J. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80149-x · Cited by 1,303
Klaman, L. D., Boss, O., Peroni, O. D., Kim, J. K., Martino, J. L., Zabolotny, J. M., Moghal, N., Lubkin, M., Kim, Y.-B., Sharpe, A. H., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5479-5489.2000 · Cited by 1,235
Pharmacologic Therapy for Type 2 Diabetes Mellitus
DeFronzo, R. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-4-199908170-00008 · Cited by 1,173
Cheatham, B., Vlahos, C. J., Cheatham, L., Wang, L., Blenis, J., & Kahn, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4902 · Cited by 1,068
Insulin Action, Diabetogenes, and the Cause of Type II Diabetes
Kahn, C. R. (1994) · Diabetes · doi:10.2337/diab.43.8.1066 · Cited by 916
Divergent Signaling Capacities of the Long and Short Isoforms of the Leptin Receptor
Bjørbæk, C., Uotani, S., da Silva, B., & Flier, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32686 · Cited by 890 · cited 1×
“Activated Jak-2 phosphorylates Tyr1138 of Ob-R1, creating a docking site for the SH2 domain of STAT3 (signal transducers and activators of transcription 3) [52].”
BackgroundUnger, R. H. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104057 · Cited by 875
PTP1B Regulates Leptin Signal Transduction In Vivo
Zabolotny, J. M., Bence-Hanulec, K. K., Stricker-Krongrad, A., Haj, F., Wang, Y., Minokoshi, Y., Kim, Y.-B., Elmquist, J. K., Tartaglia, L. A., Kahn, B. B., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00148-x · Cited by 815
Protein tyrosine phosphatases in signal transduction
Neel, B. G., & Tonks, N. K. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80063-4 · Cited by 753
Friedman, J. M. (2000) · Nature · doi:10.1038/35007504 · Cited by 702
The IRS-signalling system: A network of docking proteins that mediate insulin action
White, M. F. (1998) · Insulin Action · doi:10.1007/978-1-4615-5647-3_1 · Cited by 667
Insulin signaling pathways in time and space
Saltiel, A. R., & Pessin, J. E. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02207-3 · Cited by 628
Frangioni, J. V., Beahm, P. H., Shifrin, V., Jost, C. A., & Neel, B. G. (1992) · Cell · doi:10.1016/0092-8674(92)90190-n · Cited by 595
Structural Basis for Phosphotyrosine Peptide Recognition by Protein Tyrosine Phosphatase 1B
Jia, Z., Barford, D., Flint, A. J., & Tonks, N. K. (1995) · Science · doi:10.1126/science.7540771 · Cited by 581
Attenuation of Leptin Action and Regulation of Obesity by Protein Tyrosine Phosphatase 1B
Cheng, A., Uetani, N., Simoncic, P. D., Chaubey, V. P., Lee-Loy, A., McGlade, C. J., Kennedy, B. P., & Tremblay, M. L. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00149-1 · Cited by 546
The IRS-signalling system: A network of docking proteins that mediate insulin action
White, M. F. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006806722619 · Cited by 534
Activation of phosphatidylinositol 3-kinase by insulin.
Ruderman, N. B., Kapeller, R., White, M. F., & Cantley, L. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1411 · Cited by 524
Signaling Mechanisms That Regulate Glucose Transport
Czech, M. P., & Corvera, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.1865 · Cited by 515
TYK2 and JAK2 Are Substrates of Protein-tyrosine Phosphatase 1B
Myers, M. P., Andersen, J. N., Cheng, A., Tremblay, M. L., Horvath, C. M., Parisien, J.-P., Salmeen, A., Barford, D., & Tonks, N. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100583200 · Cited by 474
Kenner, K. A., Anyanwu, E., Olefsky, J. M., & Kusari, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19810 · Cited by 433
Zhang, Z.-Y. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.083001.144616 · Cited by 433
Self-citationGoldstein, B. J., Bittner-Kowalczyk, A., White, M. F., & Harbeck, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4283 · Cited by 419
Zinker, B. A., Rondinone, C. M., Trevillyan, J. M., Gum, R. J., Clampit, J. E., Waring, J. F., Xie, N., Wilcox, D., Jacobson, P., Frost, L., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142298199 · Cited by 414
Puius, Y. A., Zhao, Y., Sullivan, M., Lawrence, D. S., Almo, S. C., & Zhang, Z.-Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13420 · Cited by 404
Self-citationLipoapoptosis in Beta-cells of Obese Prediabeticfa/fa Rats
Shimabukuro, M., Higa, M., Zhou, Y.-T., Wang, M.-Y., Newgard, C. B., & Unger, R. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32487 · Cited by 395
Insulin signal transduction through protein kinase cascades
Avruch, J. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006823109415 · Cited by 365
Protein tyrosine phosphatases: prospects for therapeutics
Zhang, Z.-Y. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00223-4 · Cited by 348
Self-citationProtein Tyrosine Phosphatase 1B Interacts With the Activated Insulin Receptor
Seely, B. L., Staubs, P. A., Reichart, D. R., Berhanu, P., Milarski, K. L., Saltiel, A. R., Kusari, J., & Olefsky, J. M. (1996) · Diabetes · doi:10.2337/diab.45.10.1379 · Cited by 317
Deconstructing Type 2 Diabetes
Taylor, S. I. (1999) · Cell · doi:10.1016/s0092-8674(00)80709-6 · Cited by 307
Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction
Byon, J. C. H., Kusari, A. B., & Kusari, J. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006868409841 · Cited by 269
Zhang, Z.-Y. (1998) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409239891204161 · Cited by 260
Self-citationBandyopadhyay, D., Kusari, A., Kenner, K. A., Liu, F., Chernoff, J., Gustafson, T. A., & Kusari, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1639 · Cited by 257
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1994) · Diabetes · doi:10.2337/diab.43.4.587 · Cited by 246
Ghosh, S., Watanabe, R. M., Valle, T. T., Hauser, E. R., Magnuson, V. L., Langefeld, C. D., Ally, D. S., Mohlke, K. L., Silander, K., Kohtamäki, K., et al. (2000) · The American Journal of Human Genetics · doi:10.1016/s0002-9297(07)62948-6 · Cited by 238
Lembertas, A. V., Pérusse, L., Chagnon, Y. C., Fisler, J. S., Warden, C. H., Purcell-Huynh, D. A., Dionne, F. T., Gagnon, J., Nadeau, A., Lusis, A. J., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119637 · Cited by 232
Ahmad, F., Li, P.-M., Meyerovitch, J., & Goldstein, B. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20503 · Cited by 229
Malamas, M. S., Sredy, J., Moxham, C., Katz, A., Xu, W., McDevitt, R., Adebayo, F. O., Sawicki, D. R., Seestaller, L., Sullivan, D., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990560c · Cited by 216
Substrate specificity of the protein tyrosine phosphatases.
Zhang, Z., Thieme-Sefler, A. M., Maclean, D., McNamara, D. J., Dobrusin, E. M., Sawyer, T. K., & Dixon, J. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4446 · Cited by 190
Self-citationDi Paola, R., Frittitta, L., Miscio, G., Bozzali, M., Baratta, R., Centra, M., Spampinato, D., Santagati, M. G., Ercolino, T., Cisternino, C., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339270 · Cited by 186
Shen, K., Keng, Y.-F., Wu, L., Guo, X.-L., Lawrence, D. S., & Zhang, Z.-Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106568200 · Cited by 183
Self-citationProtein-tyrosine phosphatases: Structure, mechanism, and inhibitor discovery
Burke, T. R., & Zhang, Z. (1998) · Biopolymers · doi:10.1002/(sici)1097-0282(1998)47:3<225::aid-bip3>3.0.co;2-o · Cited by 181
Self-citationCellular and Molecular Mechanisms of Non-Insulin Dependent Diabetes Mellitus
Kruszynska, Y. T., & Olefsky, J. M. (1996) · Journal of Investigative Medicine · doi:10.1177/108155899604400806 · Cited by 176
Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor
Carpenter, L. R., Farruggella, T. J., Symes, A., Karow, M. L., Yancopoulos, G. D., & Stahl, N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6061 · Cited by 175
Li, C., & Friedman, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9677 · Cited by 175
Iversen, L. F., Andersen, H. S., Branner, S., Mortensen, S. B., Peters, G. H., Norris, K., Olsen, O. H., Jeppesen, C. B., Lundt, B. F., Ripka, W., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10300 · Cited by 168
Identification of Tyrosine Phosphatases That Dephosphorylate the Insulin Receptor
Wälchli, S., Curchod, M.-L., Gobert, R. P., Arkinstall, S., & van Huijsduijnen, R. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9792 · Cited by 167
Rondinone, C. M., Trevillyan, J. M., Clampit, J., Gum, R. J., Berg, C., Kroeger, P., Frost, L., Zinker, B. A., Reilly, R., Ulrich, R., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2405 · Cited by 159
Li, L., & Dixon, J. E. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0209 · Cited by 142
Myers, F. A., Evans, D. R., Clayton, A. L., Thorne, A. W., & Crane‐Robinson, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009472200 · Cited by 135
Sekar, N., Li, J., & Shechter, Y. (1996) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239609108721 · Cited by 131
Ahmad, F., & Goldstein, B. J. (1995) · Metabolism · doi:10.1016/0026-0495(95)90012-8 · Cited by 127
Wrobel, J. E., Sredy, J., Moxham, C., Dietrich, A., Li, Z., Sawicki, D. R., Seestaller, L. M., Wu, L., Katz, A. H., Sullivan, D. S., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990260v · Cited by 125
Self-citationKusari, J., Kenner, K. A., Suh, K. I., HILL, D. E., & Henry, R. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117068 · Cited by 123
From Vanadis to Atropos: vanadium compounds as pharmacological tools in cell death signalling
Morinville, A., Maysinger, D., & Shaver, A. G. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01257-7 · Cited by 121
Structural Basis of Plasticity in Protein Tyrosine Phosphatase 1B Substrate Recognition,
Sarmiento, M., Puius, Y. A., Vetter, S. W., Keng, Y., Wu, L., Zhao, Y. C., Lawrence, D. S., Almo, S. C., & Zhang, Z. (2000) · Biochemistry · doi:10.1021/bi000319w · Cited by 119
Self-citationLiljebris, C., Larsen, S. D., Ogg, D., Palazuk, B. J., & Bleasdale, J. E. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm011100y · Cited by 113
McGuire, M. C., Fields, R. M., Nyomba, B. L. G., Raz, I., Bogardus, C., Tonks, N. K., & Sommercorn, J. (1991) · Diabetes · doi:10.2337/diab.40.7.939 · Cited by 113
Echwald, S. M., Bach, H., Vestergaard, H., Richelsen, B., Kristensen, K., Drivsholm, T., Borch‐Johnsen, K., Hansen, T. F., & Pedersen, O. B. (2002) · Diabetes · doi:10.2337/diabetes.51.1.1 · Cited by 93
Dynamics of Protein-tyrosine Phosphatases in Rat Adipocytes
Calera, M. R., Vallega, G., & Pilch, P. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6308 · Cited by 91
Protein Tyrosine Phosphatase 1B
Cook, W. S., & Unger, R. H. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00158-2 · Cited by 91
Regulation of insulin receptor signaling by protein-tyrosine dephosphorylation.
Bj, G. (1993) · PubMed · Cited by 88
Maegawa, H., Ide, R., Hasegawa, M., Ugi, S., Egawa, K., Iwanishi, M., Kikkawa, R., Shigeta, Y., & Kashiwagi, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7724 · Cited by 87
Regulation of protein tyrosine phosphatases by insulin and insulin-like growth factor I.
Kenner, K. A., HILL, D. E., Olefsky, J. M., & Kusari, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74413-5 · Cited by 78
Probing the Molecular Basis for Potent and Selective Protein-tyrosine Phosphatase 1B Inhibition
Guo, X.-L., Shen, K., Wang, F., Lawrence, D. S., & Zhang, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207347200 · Cited by 72
Self-citationRecent discovery and development of protein tyrosine phosphatase inhibitors
Kim, H.-O., & Blaskovich, M. A. T. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.6.871 · Cited by 62
Protein tyrosine phosphatases: their role in insulin action and potential as drug targets
Evans, J. L., & Jallal, B. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.2.139 · Cited by 61
Structural Studies of Reversible Protein Phosphorylation and Protein Phosphatases
Barford, D. (1999) · Biochemical Society Transactions · doi:10.1042/bst0270751 · Cited by 34
Kole, H. K., Liotta, A. S., Kole, S., Roth, J., Montrose‐Rafizadeh, C., & Bernier, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31619 · Cited by 18
Cited by
Bhatti, J. S., Sehrawat, A., Mishra, J., Sidhu, I. S., Navik, U., Khullar, N., Kumar, S., Bhatti, G. K., & Reddy, P. H. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.03.019 · Cited by 693
PTP1B as a drug target: recent developments in PTP1B inhibitor discovery
Zhang, S., & Zhang, Z.-Y. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.03.011 · Cited by 558
Self-citationMolecular Mechanisms and Clinical Implications of Reversible Protein S -Glutathionylation
Mieyal, J. J., Gallogly, M. M., Qanungo, S., Sabens, E. A., & Shelton, M. D. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2089 · Cited by 523
Recent applications of multicomponent reactions in medicinal chemistry
Slobbe, P., Ruijter, E., & Orru, R. V. A. (2012) · MedChemComm · doi:10.1039/c2md20089a · Cited by 484
Protein tyrosine phosphatases as potential therapeutic targets
He, R.-J., Yu, Z.-H., Zhang, R.-Y., & Zhang, Z.-Y. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.80 · Cited by 327
Self-citation
Metadata
- Authors
- Zhang, Z.-Y., & Lee, S.-Y.
- Venue
- Expert Opinion on Investigational Drugs
- Publisher
- Informa Healthcare
- Published
- 2003-02
- Volume
- 12
- Issue
- 2
- Pages
- 223-233
- ISSN
- 1354-3784 (ISSN-L)
- 1744-7658
- OpenAlex
- W2090727292
- Cited by
- 271
- References
- 78
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.